Understanding Diabetes in Women: The Role of Hormones
For women with diabetes, the interplay of hormones and blood sugar regulation presents unique challenges. Several factors, including the menstrual cycle, pregnancy, menopause, and conditions like Polyendocrine Metabolic Ovarian Syndrome (PMOS), impact blood sugar levels, making tailored care and counseling essential.
The Impact of Hormones on Insulin Sensitivity
Women often experience fluctuations in their bodies that can complicate diabetes management. Hormones such as estrogen and progesterone directly influence insulin’s effectiveness. Notably, during the luteal phase of the menstrual cycle, insulin requirements can increase by up to 15%. However, many modern insulin pump systems struggle to accommodate these variations, leaving women to manually adjust their therapy.
Professor Dr. Susanne Reger-Tan, head of the Diabetes and Endocrinology Clinic at the Heart and Diabetes Center NRW, highlights the intricate adjustments women have to make each month. “They monitor, compare, and correct their dosages,” she explains, emphasizing the necessity for counseling that acknowledges these hormonal changes.
PMOS and Menopause: The Unpredictability of Diabetes
PMOS, previously known as Polycystic Ovary Syndrome (PCOS), illustrates the deep connections between hormones, weight, blood sugar, and cardiovascular health. Affecting approximately one in eight women, PMOS frequently goes undiagnosed. The recent name change reflects the condition’s complexity, encompassing various metabolic disturbances beyond just ovarian function.
During menopause, the situation can become even more unpredictable for women with diabetes. As estrogen levels drop, insulin sensitivity changes, leading to fluctuating glucose levels. Research indicates that about two-thirds of women with type 1 diabetes report more unstable blood sugar values post-menopause. Symptoms like sweating, trembling, and palpitations can mimic hot flashes or hypoglycemia, making it crucial to check glucose levels to avoid missed hypoglycemic episodes.
Gestational Diabetes: A Normal Part of Pregnancy
Gestational diabetes can emerge unexpectedly during pregnancy, often leading to anxiety for women who may question their actions. However, this condition is frequently hormonally induced and not a sign of personal failure. Approximately 10% of pregnant women are affected, with blood sugar levels typically normalizing after delivery. Still, the risk of developing type 2 diabetes later in life increases seven to eightfold.
Dr. Judith Scholler-Sachs, a diabetes consultant and midwife, emphasizes that women need supportive, individualized care post-pregnancy. “Women deserve practical prevention strategies tailored to their family’s needs,” she asserts, advocating for education and strategies to shield both mother and child from future diabetes risks.
The Mental Load of Diabetes
Diabetes doesn’t disappear after a doctor’s visit; it pervades daily life. A survey revealed that individuals with diabetes actively think about their condition for an average of 77 minutes each day. Women reported a median of 60 minutes, compared to 30 minutes for men. This persistent mental load adds another layer of complexity to managing diabetes, as it involves planning meals, monitoring glucose, and managing family dynamics.
Laura Klinker, a psychologist, points out that many women bear the invisible burden of juggling diabetes management with other responsibilities. Research shows that women with diabetes experience higher stress levels, more stigma, and lower quality of life compared to their male counterparts. Further investigation is necessary to fully understand the impact of this mental overload on female diabetes patients.
Addressing Care Gaps and Medical Gaslighting
Many women find their health concerns dismissed, with symptoms misattributed to stress or psychological factors, a phenomenon known as medical gaslighting. Theresia Schoppe of the VDBD emphasizes that when women receive delayed diagnoses or less rigorous treatment, it’s indicative of broader healthcare disparities.
Data indicates that women with type 2 diabetes and associated cardiovascular or kidney issues receive protective medications less frequently than men, reducing the likelihood of guideline-recommended therapies by 33%. Personalized treatment approaches could significantly lower the risk of therapy failure.
Guidance for Women with Diabetes
The VDBD advises women not to overlook bodily changes that may affect their diabetes management. Factors such as hormonal shifts, stress, sleep, and psychological wellbeing can all influence treatment. It’s imperative to monitor glucose levels when experiencing unexplained symptoms and to engage in postpartum follow-ups following gestational diabetes. Women should feel empowered to address feelings of persistent fatigue during counseling sessions.
Diabetes management extends beyond blood sugar numbers; it involves recognizing patterns and navigating life stages where new challenges arise. Understanding that changing dynamics in diabetes should not invoke guilt, but instead warrant proactive discussions with healthcare providers is crucial for all women managing this condition.
